Clinical Trial Update: The Effects of Empagliflozin on Arterial Wall Characteristics [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effects of empagliflozin on arterial wall characteristics in individuals with vascular stiffness and diabetes-related conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Complications
• Type 1 Diabetes Mellitus
• Vascular Stiffness

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Vascular Stiffness, Hypoglycemic Agents | Phase 4 | Status: UNKNOWN